Prevention of Atrial Fibrillation in Cardiac Surgery: Time to Consider a Multimodality Pharmacological Approach
- 11 January 2010
- journal article
- review article
- Published by Wiley in Cardiovascular Therapeutics
- Vol. 28 (1), 59-65
- https://doi.org/10.1111/j.1755-5922.2009.00117.x
Abstract
Atrial fibrillation (AF) is very common within the first 5 days of cardiac surgery. It is associated with significant morbidity including stroke, ventricular arrhythmias, myocardial infarction, heart failure, acute kidney injury, prolonged hospital stay, and also short- and long-term mortality. The underlying mechanisms of developing AF after cardiac surgery are multifactorial; risk factors may include advanced age, withdrawal of beta-blockers and angiotensin-converting-enzyme inhibitors, valve surgery, obesity, increased left atrial size, and diastolic dysfunction. There are many pharmacological options in preventing AF, but none of them are effective for all patients and they all have significant limitations. Beta-blockers may reduce the incidence of AF by more than a third, but bradycardia, hypotension, or exacerbation of heart failure often limit their utility postoperatively. Recent evidence suggests that class III antiarrhythmic drugs, sotalol and amiodarone, are more effective than beta-blockers, but they both share similar hemodynamic side effects of beta-blockers. Magnesium, antiinflammatory drugs such as statins, omega fatty acids, and low-dose corticosteroids also have some efficacy and they have the advantages of not causing significant hemodynamic side effects. Data on effectiveness of calcium channel blockers, digoxin, alpha-2 agonists, sodium nitroprusside, and N-acetylcysteine are more limited. Because the pathogenesis of AF is multifactorial, a combination of drugs with different pharmacological actions may have additive or synergistic effect in preventing AF after cardiac surgery. Randomized controlled trials evaluating the effectiveness of a multimodality pharmacological approach in patients at high-risk of AF after cardiac surgery are needed.Keywords
This publication has 44 references indexed in Scilit:
- New-Onset Postoperative Atrial Fibrillation After Isolated Coronary Artery Bypass Graft Surgery and Long-Term SurvivalCirculation: Cardiovascular Quality and Outcomes, 2009
- Prevention of perioperative atrial fibrillation with betablockers in coronary surgery: betaxolol versus metoprololInteractive CardioVascular and Thoracic Surgery, 2009
- Magnesium sulphate and amiodarone prophylaxis for prevention of postoperative arrhythmia in coronary by-pass operationsJournal of Cardiothoracic Surgery, 2009
- Milrinone Use Is Associated With Postoperative Atrial Fibrillation After Cardiac SurgeryCirculation, 2008
- Expecting the UnexpectedAnesthesia & Analgesia, 2008
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial FibrillationCirculation, 2006
- Intraoperative and Postoperative Variables Associated with Strokes following Cardiac SurgeryThe Heart Surgery Forum, 2004
- Antiarrhythmic effect of magnesium sulfate after open heart surgery: effect of blood levelsInternational Journal of Cardiology, 2003
- Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass graftingThe American Journal of Cardiology, 1991
- Risk factors for atrial fibrillation after coronary artery bypass graftingThe American Journal of Cardiology, 1990